1. Home
  2. MGIH vs LEXX Comparison

MGIH vs LEXX Comparison

Compare MGIH & LEXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Millennium Group International Holdings Limited

MGIH

Millennium Group International Holdings Limited

HOLD

Current Price

$1.25

Market Cap

14.4M

ML Signal

HOLD

Logo Lexaria Bioscience Corp.

LEXX

Lexaria Bioscience Corp.

HOLD

Current Price

$0.62

Market Cap

14.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MGIH
LEXX
Founded
1978
2004
Country
Hong Kong
Canada
Employees
N/A
N/A
Industry
Publishing
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
14.4M
14.5M
IPO Year
2023
N/A

Fundamental Metrics

Financial Performance
Metric
MGIH
LEXX
Price
$1.25
$0.62
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$1.50
AVG Volume (30 Days)
46.2K
1.5M
Earning Date
10-28-2025
01-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$25,334,149.00
$705,923.00
Revenue This Year
N/A
$13.35
Revenue Next Year
N/A
$78.83
P/E Ratio
N/A
N/A
Revenue Growth
N/A
52.05
52 Week Low
$1.11
$0.46
52 Week High
$4.84
$2.43

Technical Indicators

Market Signals
Indicator
MGIH
LEXX
Relative Strength Index (RSI) 43.39 38.76
Support Level $1.22 $0.46
Resistance Level $1.41 $0.64
Average True Range (ATR) 0.10 0.12
MACD 0.00 -0.02
Stochastic Oscillator 25.00 17.90

Price Performance

Historical Comparison
MGIH
LEXX

About MGIH Millennium Group International Holdings Limited

Millennium Group International Holdings Ltd supplies paper-based packaging solutions, including inner packaging boxes produced with offset or flexo printing and outer corrugated boxes used for transportation, storage, pallets, and point-of-purchase displays. The company manufactures corrugated products of different sizes, shapes, thicknesses, and strengths according to customer specifications. It also operates a supply chain management business in Vietnam to service international clients who source their packaging needs from Vietnam and other ASEAN countries. The corrugated paper is durable, versatile, economical, and lightweight.

About LEXX Lexaria Bioscience Corp.

Lexaria Bioscience Corp is a biotechnology company focused on enhancing the bioavailability of active pharmaceutical ingredients using its patented DehydraTECH drug delivery technology. DehydraTECH improves absorption, effectiveness, and tolerability and can be applied to APIs such as GLP-1 and GIP drugs, vitamins, pain medications, hormones, antivirals, nicotine and cannabinoids across therapeutic areas including diabetes, weight loss, epilepsy, hypertension, and heart disease. It can be used in formats such as tablets, capsules, oral suspensions, foods, beverages, and pouches, and supports pharmaceuticals, nutraceuticals, over-the-counter products, and consumer packaged goods. The Company operates one segment: IP licensing, generating revenue from licensing its DehydraTECH technology.

Share on Social Networks: